Enoblituzumab Uses, Dosage, Side Effects and more
Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
| Trade Name | Enoblituzumab |
| Generic | Enoblituzumab |
| Enoblituzumab Other Names | Enoblituzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
